Risperdal Lawsuit Filings May End In Settlement

April 10, 2017 – – More than 18,000 Risperdal cases have been filed against pharmaceutical giant Johnson & Johnson. The company faces over 100,000 total lawsuits to date, a huge portion of which involve the drug Risperdal, which is an antipsychotic used to treat schizophrenia and other psychotic disorders. A spokesperson for www.risperdal-settlement.com recently stated that many of those lawsuits may end in settlements.

“We’ve seen the company settle with plaintiffs just days before their cases go to trial,” says the spokesperson. “We believe that they will settle many of the additional cases as more and more are being filed every day.”

Many of the cases filed against Johnson & Johnson have already ended in settlement while many others remain slated for trial. Legal experts believe that as more and more claims are filed, the company will avoid the repercussions of jury trials and end those cases in a settlement with the plaintiffs.

Risperdal has been associated with a wide range of serious side effects including blood clots, weight gain, vision problems, and various others. The main allegation in the various lawsuits, however, is that the medication causes gynecomastia in men and boys, a condition which causes growth of breast tissue.

“Many of these cases involve men who began taking Risperdal as young boys, before it was approved for use in children,” says the spokesperson for the Risperdal settlement website. “In one case, a man began taking the medication at the age of eight, four years before it was approved to be taken by anyone under the age of 18.”

Risperdal initially carried a warning label that listed gynecomastia as a less severe side effect. Lawsuits, however, claim that it is a severe consequence of taking the medication and more claims continue to come in. Cases that have gone to trial have ended with verdicts for the plaintiffs. Settlements in court have reached amounts as high as $70 million.

As claims continue to be filed it is unsure whether Johnson & Johnson will actually end all of them in out of court settlements. Legal experts continue to debate on whether or not a trial by jury is the best way for the company to handle the issue, and many believe that settling with current cases would set a strong precedent for future cases that may be filed.

###

Contact Drug-Lawsuits.org:

info@drug-lawsuits.org

ReleaseID: 60016889